Login to Your Account

NeoStem Adds to Stem Cell Mix with $18M Amorcyte Buy

By Trista Morrison

Monday, July 18, 2011
NeoStem Inc. – which has its hands in a variety of cell therapy businesses including early stage research, storage, manufacturing and overseas treatment – is acquiring privately held stem cell firm Amorcyte Inc.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription